Key learning objectives
- Explore the interconnected relationship between conditions of the CRM system across type 2 diabetes
- Understand the wider impact and increased risks associated with having one or more conditions affecting the CRM system
- Consider the unmet clinical need related to CRM morbidity and mortality in patients with type 2 diabetes
- Understand how clinical guidance for type 2 diabetes has been updated to reflect the results of positive cardiovascular outcome trials
- Reflect on the overall goals of treatment and individualised care for patients with type 2 diabetes
Speakers:
- Louise Dodd, Medical education associate, Lilly
- Dr Yassir Javaid, GPWSi, Northampton
Your contact details will be shared with Lilly.